Eli Lilly (LLY) PT Raised to $112 at Barclays
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,270.39 +3.64%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Barclays analyst Geoff Meacham raised the price target on Eli Lilly (NYSE: LLY) to $112.00 (from $107.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
- Home Depot (HD) PT Raised to $354 at Bernstein SocGen Group
- Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
